Syngen Biotech Co.,Ltd. (TPEX:8279)
Taiwan · Delayed Price · Currency is TWD 99.10
+2.40 (2.48%)
May 8, 2026, 1:30 PM CST
Syngen Biotech Market Cap
Syngen Biotech has a market cap or net worth of 2.69 billion as of May 8, 2026. Its market cap has decreased by -16.72% in one year.
Market Cap
2.69B
Enterprise Value
2.53B
Revenue
2.07B
Ranking
n/a
PE Ratio
11.31
Stock Price
99.10
Market Cap Chart
Since November 2, 2004, Syngen Biotech's market cap has increased from 372.00M to 2.69B, an increase of 621.96%. That is a compound annual growth rate of 9.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 2.69B | -14.57% |
| Dec 31, 2025 | 3.14B | -8.66% |
| Dec 30, 2024 | 3.44B | -16.45% |
| Dec 29, 2023 | 4.12B | -6.17% |
| Dec 30, 2022 | 4.39B | 43.36% |
| Dec 30, 2021 | 3.06B | 4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.21B |
| Genovate Biotechnology | 3.09B |
| TWi Biotechnology | 3.03B |
| Intech Biopharm | 3.02B |
| BRIM Biotechnology | 2.98B |
| Chunghwa Chemical Synthesis & Biotech | 2.98B |
| HeXun Biosciences | 2.85B |
| Apex Biotechnology | 2.83B |